glp 1 agonist therapy Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive GLP-1 Receptor Agonists: The New
Description
Cantini G, Di Franco A, Samavat J, Forti G, Mannucci E, Luconi M

Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study

Higher doses could cost as much as $349 a month or $299 for those who refill within 45 days

Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment

In fact, most reports show a reduction in rates, but I would never argue with someone who says we need to learn more
